Impact of AMATEA™️ on Physiological Measures and Gaming Performance in Active Gamers: a Placebo Controlled, Double-blind, Randomized Study
NCT ID: NCT04234529
Last Updated: 2021-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
59 participants
INTERVENTIONAL
2020-02-01
2021-06-11
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of the present study is to compare the effects of AMATEA and caffeine alone on various measures of cognitive performance, mood, and gaming performance in men and women who regularly engage in gaming activity. The investigators hypothesize that both AMATEA and caffeine will improve outcome measures more than placebo, with greater improvement noted for the AMATEA condition due to the addition of the chlorogenic acid.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Active gamers claim to ingest such products regularly throughout their gameplay, which can span from 4-12 hours per session for regular gamers. AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee). The product is also Generally Recognized as Safe (GRAS) and USDA organic.
While caffeine has been well-investigated for its performance boosting effects, chlorogenic acid has been reported to offer many potential health benefits. Specifically, it has been reported to improve select cognitive measures following regular intake, which may translate into more efficient performance with complex tasks-such as those involved with gaming.
In-house evaluations and anecdotal findings related to AMATEA have noted sustained energy without the typical "crash" and/or "jitters" experienced by some with caffeine ingestion alone. While caffeine can prove beneficial to many, some users experience "crashing" 2-3 hours post ingestion, while others feel too "wired" following use and may experience difficulty concentrating. AMATEA contains a relatively low concentration of caffeine per capsule (150mg) in an attempt to avoid such problems, while also containing chlorogenic acid. This may aid gamers who need to maintain fine motor skills and those who need to concentrate on complex activities for several hours continuously.
The aim of the present study is to compare the effects of AMATEA and caffeine alone on various measures of cognitive performance, mood, and gaming performance in men and women who regularly engage in gaming activity. The investigators hypothesize that both AMATEA and caffeine will improve outcome measures more than placebo, with greater improvement noted for the AMATEA condition due to the addition of the chlorogenic acid.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
CROSSOVER
BASIC_SCIENCE
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
AMATEA
3x 450mg capsules of AMATEA which contains 270mg of caffeine total
AMATEA™
AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee).
Total of 1.35g of AMATEA containing 270mg of caffeine.
Caffeine
3x 450mg capsules each containing 360mg of microcellulose and 90mg of caffeine (270mg caffeine total)
Caffeine
1.08g of microcellulose and 270mg of caffeine.
Placebo
3x 450mg capsules of microcellulose
Placebo
1.35g of microcellulose
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
AMATEA™
AMATEA™ is a patented dietary supplement consisting of a unique blend of caffeine and polyphenol antioxidants; standardized at 20% caffeine, 30% chlorogenic acids (similar to green coffee).
Total of 1.35g of AMATEA containing 270mg of caffeine.
Caffeine
1.08g of microcellulose and 270mg of caffeine.
Placebo
1.35g of microcellulose
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* male or female
* body mass index (BMI) between 18-34.9 kg/m2
* not be using tobacco products
* no diagnosed history of diabetes
* no diagnosed history of cardiovascular disease
* no diagnosed history of neurological disease
* no consumption of alcohol within 48 hours of testing
* consume \< 400mg caffeine daily
* no consumption of caffeine-containing beverages within at least 48 hours of testing
* blood metabolic parameters within normal limits
* if female, not be pregnant
* active gamers: playing at least 4 days per week, for at least 4 hours per day, for the past 12 months
* regularly playing the game Fortnite, for the past 3 months
* willing to play on our console systems and use their personal headset
Exclusion Criteria
* individuals weighing less than 115 pounds
* individuals with a BMI less than 18kg/m2 or greater than 35kg/m2
* individuals with a diagnosed history of diabetes, cardiovascular disease, or neurological disease
* individuals that consume greater than 400mg caffeine daily
* pregnant females
* non-active gamers
18 Years
40 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Applied Food Sciences, Inc.
UNKNOWN
University of Memphis
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Richard Bloomer
Dean of School of Health Studies
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Richard Bloomer, Ph.D.
Role: PRINCIPAL_INVESTIGATOR
University of Memphis
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Nutraceutical and Dietary Supplement Research
Memphis, Tennessee, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PRO-FY2020-65
Identifier Type: -
Identifier Source: org_study_id